RCM
IMA

RA Capital Management’s ImageneBio Inc IMA Stock Holding History

RA Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-62,500
Closed -$9.4M – 100
2021
Q4 		$9.4M Hold
62,500
– – 0.17% 85
2021
Q3 		$9.46M Hold
62,500
– – 0.13% 80
2021
Q2 		$10.5M Hold
62,500
– – 0.17% 73
2021
Q1 		$21.2M Buy
+62,500
New +$21.4M 0.32% 55

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RA Capital Management's IMA Position: Q1 2022 in Review

RA Capital Management sold out of ImageneBio Inc (IMA) in Q1 2022, closing a stake of 62,500 shares — an estimated $9.4M sold.

RA Capital Management first reported a position in IMA in Q1 2021 and held it in 4 quarters. The position peaked at $21.2M in Q1 2021. 48 funds tracked by Wall St. Rank hold IMA as of Q1 2022.

  • RA Capital Management reported no remaining ImageneBio Inc position as of Q1 2022 after selling out during the quarter.
  • RA Capital Management sold 62,500 ImageneBio Inc shares in Q1 2022, an estimated $9.4M.
  • RA Capital Management first reported a position in ImageneBio Inc in Q1 2021 and held it in 4 quarters.
  • RA Capital Management's ImageneBio Inc position peaked at $21.2M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2022.

Based on RA Capital Management's 13F filing for Q1 2022, filed 16 May 2022.